[1] Xu ZY,Yang JH,Xu Y, et al. Liver biopsy results in female patients with unexplained liver injury: an analysis of 109 cases.Zhonghua Gan Zang Bing Za Zhi, 2017,25:38-39. [2] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018 年更新版). 实用肝脏病杂志,2018,21: 177-186. [3] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 临床肝胆病杂志,2015,31(11): 1752-1769. [4] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会. 自身免疫性肝炎诊断和治疗共识(2015). 临床肝胆病杂志,2016,32:9-22. [5] 杨亚婷,闫力,陈红等.《2016年美国胃肠病学会临床指南:异常肝生化指标的评估》摘译.临床肝胆病杂志,2017,33:632-637. [6] 何亚男,郑长清. 血清自身抗体检测对自身免疫性肝病的研究进展.胃肠病学和肝病学杂志,2020,29:104-107. [7] LIU YJ. Expression of autoantibody in autoimmune liver diseasesand its clinical value. China Prac Med,2013,28: 102-103. 刘燕京.自身抗体在自身免疫性肝病中的表达及临床价值. 中国实用医药,2013,28:102-103. [8] 王艳萍,邹麟,唐良君,等. 自身免疫性肝病临床及实验室特征分析.国际检验医学杂志,2020,41:56-64. [9] Apel K, Pütz K,Tolkach Y,et al.Drug-induced liver injury-significance of pathology. Pathologe, 2020,41:457-470. [10] Czaja AJ.Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci,2011,56: 545-554. [11] 崔娜娜,王绮夏.自身免疫性肝炎的鉴别与诊断. 临床肝胆病杂志,2020,36: 724-727. [12] YU K, LI P, XU T, et al. Decreased infiltration of CD4+ Th1 cells indicates a good response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis. Pathol Res Pract.2021,217:153291. [13] 苗琪,马雄. 自身免疫性肝炎与药物性肝损伤: 鉴别诊断和处理. 中华肝脏病杂志,2012,20: 327-329. [14] Lin CJ,Hu ZG,Yuan GD, et al. Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis. World J Hepatol, 2018,10:662-669. [15] 崔娜娜,王绮夏,马雄. 2019 年美国肝病学会实践指引和指南:《成人和儿童自身免疫性肝炎的诊断与治疗》摘译. 临床肝胆病杂志,2020,36: 758-763. |